The dentist started recommending the CloSYS mouthwash and patients going through chemo found it not only eased the pain of their mouth sores, but it eliminated them.

During the past two years, Rowpar received 10 patents in the U.S., Europe, Canada, Australia, Japan and Mexico. James Ratcliff and his father, Dr. Perry Ratcliff, teamed with other dental ...

CloSys Corp. is seeking $2.38 million from the sale of equity, according to documents filed with the Securities and Exchange Commission. The company, based in New Brighton, Minnesota, already has ...

A Minnesota startup developing a vascular closure device is looking to raise $2.5 million in debt and options, according to a regulatory filing. It has raised $30,000 so far. CloSys Corp. has been ...

CloSys Corp. — a St. Paul med-tech that has developed a device for better closing the artery in the groin after a catheterization — is seeking to raise an additional $2.5 million from ...

Scottsdale firm bringing high-end oral care product into China Rowpar Pharmacuticals Inc. is working to expand sales of its oral-care line to China. The Scottsdale company’s CloSYS products ...

MINNEAPOLIS, MN / ACCESSWIRE / December 8, 2014 / CloSys Corporation announced today new company leadership, including a new CEO and new members of its Board of Directors.